Intensive Medical Therapy for High-risk Intracranial or Extracranial Arterial Stenosis
Status:
Recruiting
Trial end date:
2023-01-30
Target enrollment:
Participant gender:
Summary
Large-artery stenosis plays an important role in the occurrence of ischemic stroke. The
primary purpose of this study is to evaluate the efficacy and safety of intensive
antiplatelet therapy versus standard antiplatelet therapy and immediate high-intensity statin
therapy (80mg atorvastatin) versus delayed high-intensity statin therapy (40mg atorvastatin)
and intensive antiplatelet combined with immediate high-intensity statin therapy (80mg
atorvastatin) versus standard antiplatelet combined with delayed high-intensity statin
therapy (40mg atorvastatin) in reducing the risk of stroke at 90 days in patients with acute
and high-risk symptomatic extracranial or intracranial arterial stenosis.
Phase:
Phase 3
Details
Lead Sponsor:
Beijing Tiantan Hospital Ministry of Science and Technology of the People´s Republic of China
Collaborator:
Ministry of Science and Technology of the People's Republic of China